RECORD // Company

NextCure, Inc.

Built 2026-11-21T10:16:29Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
  • NEXTCURE, INC. · legal entity in this company's GLEIF ownership tree (LEI 549300Y5PR6RJR1STI24)
SEC EDGAR (1)
Matched by name only, not merged (2)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • NextCure, Inc. · Ctgov · same registered legal name as 'NextCure, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • NEXTCURE, INC. · East licences · same registered legal name as 'NextCure, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

2 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-10 · accession 0001104659-26-125220

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-6,846,0003 months ended 2026-09-3010-Q2026-11-100001104659-26-1252202026-11-21 10:16 UTCReport an error
Cash and cash equivalents$8,728,000at 2026-09-3010-Q2026-11-100001104659-26-1252202026-11-21 10:16 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue, Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001661059
Ticker
NXTC
EIN
475231247
CUSIP
65343E207
Record ID
sx:sec:0001661059

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

32 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
State of incorporationDE2026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
Fiscal year end (MMDD)12312026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
Business address2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 212092026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
ExchangesNasdaq2026-11-20SEC EDGAR company profile2026-11-21 10:16 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-55,844,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 10:16 UTCReport an error
Total assets (at 2025-12-31)$50,183,0002025-12-3110-K, XBRL Assets2026-11-21 10:16 UTCReport an error
Stockholders' equity (at 2025-12-31)$34,943,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 10:16 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$25,982,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 10:16 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-49,613,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 10:16 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2024-12-31)$474,0002024-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 10:16 UTCReport an error
Operating lease liabilities (at 2025-12-31)$5,153,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-21 10:16 UTCReport an error
Form D total offering amount (D filed 2025-12-10)$21,500,0002025-12-10D2026-11-21 10:16 UTCReport an error
Form D total amount sold (D filed 2025-12-10)$21,500,0002025-12-10D2026-11-21 10:16 UTCReport an error
Form D industry groupBiotechnology2025-12-10D2026-11-21 10:16 UTCReport an error
Form D revenue rangeNo Revenues2025-12-10D2026-11-21 10:16 UTCReport an error
Form D date of first sale2025-11-122025-12-10D2026-11-21 10:16 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-11-20)As previously disclosed, on July 14, 2026, NextCure, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among the Company, Avere Therapeutics, Inc., a Delaware corporation (“Avere”), Neptune Merger Sub Corp., a Delaware corporation and a direct, wholly owned subsidiary of the Company (“First Merger Sub”), and Neptune Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of the Company (“Second Merger Sub”). Capitalized terms used but not otherwise defined in this Current Report on Form 8-K shall have the meanings ascribed to them in the Merger Agreement…2026-11-20SEC EDGAR 8-K 0001104659-26-130620 (text as filed, excerpt)2026-11-21 10:16 UTCReport an error
8-K Item 3.01, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (filed 2026-11-20)On November 16, 2026, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that we were not in compliance with the minimum stockholders’ equity requirement applicable to companies listed on the Nasdaq Global Select Market under Listing Rule 5450(b)(1)(A) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $5,503,000, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, was below the required minimum of $10.0 million, and because, as of November 16, 2026, the…2026-11-20SEC EDGAR 8-K 0001104659-26-130409 (text as filed, excerpt)2026-11-21 10:16 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-10)On November 10, 2026, NextCure, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1. The information furnished in this Item 2.02 (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a…2026-11-10SEC EDGAR 8-K 0001104659-26-125188 (text as filed, excerpt)2026-11-21 10:16 UTCReport an error
Plan (pension, plan no. 001)NEXTCURE, INC. 401K PLAN: 84 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 10:16 UTCReport an error
Largest institutional holder #1 (13F as filed): Ikarian Capital, LLC$461,2842026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #2 (13F as filed): ADAGE CAPITAL PARTNERS GP, L.L.C.$443,5232026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #3 (13F as filed): Sofinnova Investments, Inc.$356,2462026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #4 (13F as filed): RENAISSANCE TECHNOLOGIES LLC$273,9232026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #5 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$250,9472026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #6 (13F as filed): MILLENNIUM MANAGEMENT LLC$140,9792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #7 (13F as filed): BOOTHBAY FUND MANAGEMENT, LLC$135,4992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #8 (13F as filed): Squadron Capital Management LLC$103,1422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #9 (13F as filed): Verdad Advisers, LP$96,7222026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error
Largest institutional holder #10 (13F as filed): Pfizer Inc$72,9672026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 10:16 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.